Sign up
Pharma Capital

Amryt Pharma signs exclusive Saudi Arabian distribution agreement

Dave Allmond, chief commercial officer at  Amryt Pharma PLC (LON:AMYT), discusses with Proactive the exclusive distribution agreement they've signed with Saudi Arabian firm Faisal Musaed El Seif Saudi Pharmaceutical Company.

The deal gives El Seif the right to distribute Amryt’s Lojuxta and AP101 drugs in the kingdom.

 

View full AMYT profile

Amryt Pharmaceuticals Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.